Merck (MRK) Other Operating Expenses (2010 - 2026)

Merck has disclosed Other Operating Expenses across 17 years of filings, most recently posting $4.3 billion for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 28.04% year-over-year to $4.3 billion; the TTM figure through Mar 2026 stood at $21.2 billion (up 41.05% YoY), while the FY2025 annual figure was $16.5 billion, up 8.99% from the prior year.
• Other Operating Expenses fell to $4.3 billion in Q1 2026, from $9.7 billion in the prior quarter.
• Over the last five years, Other Operating Expenses for MRK reached as high as $9.7 billion in Q4 2025 and fell as low as $3.4 billion in Q1 2025.
• The 5-year median for Other Operating Expenses is $4.0 billion (2023), against an average of $4.7 billion.
• Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 51.28% — and 2025, when it soared 145.74%.
• A 5-year view of Other Operating Expenses shows it stood at $3.8 billion in 2022, then soared by 113.27% to $8.1 billion in 2023, then tumbled by 51.28% to $4.0 billion in 2024, then soared by 145.74% to $9.7 billion in 2025, then plunged by 55.42% to $4.3 billion in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $4.3 billion, $9.7 billion, and $3.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.